Pharvaris Netherlands B.v.
Clinical trials sponsored by Pharvaris Netherlands B.v., explained in plain language.
-
New pill shows promise for rapid relief of dangerous swelling attacks
Symptom relief CompletedThis study tested an oral capsule called deucrictibant for quickly treating sudden swelling attacks in people with hereditary angioedema (HAE). Researchers compared the medication against a placebo in 134 participants aged 12-75 who experienced at least two attacks in three month…
Phase: PHASE3 • Sponsor: Pharvaris Netherlands B.V. • Aim: Symptom relief
Last updated Apr 03, 2026 14:42 UTC
-
New pill tested to stop painful swelling attacks
Symptom relief CompletedThis study tested an oral medication called deucrictibant for quickly relieving painful swelling attacks in people with hereditary angioedema (HAE). Seventy-four participants with HAE took either the study drug or a placebo pill at home when an attack started. Researchers measure…
Phase: PHASE2 • Sponsor: Pharvaris Netherlands B.V. • Aim: Symptom relief
Last updated Mar 02, 2026 15:22 UTC